For the year ending 2025-12-31, ADTX had $2,365,568 increase in cash & cash equivalents over the period. -$25,702,102 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Purchase of fixed assets | 13,743 |
| Investment in convertible notes receivable and warrants | 2,425,000 |
| Investment in evofem f-1 preferred stock | 0 |
| Net cash used in investing activities | -2,438,743 |
| Proceeds from notes payable, related party | 678,000 |
| Proceeds from notes and convertible notes payable, net of offering costs | 1,191,018 |
| Repayments of note payable, related party | -793,000 |
| Repayments of note payable | 6,613,882 |
| Common stock, preferred stock, and warrants issued for cash, net of issuance costs | 44,128,225 |
| Cash from subscription receivable | 1,108,751 |
| Redemptions of a-1 preferred stock | 308,000 |
| Redemptions of c-1 preferred stock | 8,898,442 |
| Proceeds from exercises of warrants | 0 |
| Redemptions of d-1 preferred stock | 0 |
| Net cash provided by financing activities | 30,492,670 |
| Stock-based compensation | 473,311 |
| Stock-based compensation from asset purchase | 10,000 |
| Amortization of debt discount - note payable | 1,706,697 |
| Amortization of debt discount - note receivable | 220,689 |
| Change in fair value of derivative liability | -14,515 |
| Impairment of evofem f-1 preferred stock | 23,766,209 |
| Bargain purchase gain from purchase of evofem convertible notes | -328,071 |
| Accounts receivable | -43,435 |
| Prepaid expenses | 613,983 |
| Deposits | -26,086 |
| Inventory | -5,471 |
| Accounts payable and accrued expenses | -5,632,893 |
| Net loss | -42,787,043 |
| Change in fair value of evofem warrants | -2,806,983 |
| Depreciation expense | 269,271 |
| Impairment of fixed assets | 412,005 |
| Amortization of intangible assets | 3,333 |
| Loss on note exchange agreement | 0 |
| Modification of warrants for debt issuance costs | 0 |
| New principal from extension of notes, net of debt discount | 0 |
| Disposal of fixed assets | 0 |
| Settlement liability | 0 |
| Net cash used in operating activities | -25,688,359 |
| Net increase in cash | 2,365,568 |
| Net increase in cash | 2,365,568 |
| Cash at beginning of period | 833,031 |
| Cash at end of period | 3,198,599 |
Aditxt, Inc. (ADTX)
Aditxt, Inc. (ADTX)